Inhibition of MMP-9 using a pyrrole-imidazole polyamide reduces cell invasion in renal cell carcinoma
- 21 August 2013
- journal article
- Published by Spandidos Publications in International Journal of Oncology
- Vol. 43 (5), 1441-1446
- https://doi.org/10.3892/ijo.2013.2073
Abstract
Spandidos Publications is a scientific publisher with a long-standing international reputation for excellent standards and high quality science publicationsKeywords
This publication has 18 references indexed in Scilit:
- Gastric cancer — The role of matrix metalloproteinases in tumor progressionClinica Chimica Acta; International Journal of Clinical Chemistry, 2011
- Physiology and pathophysiology of matrix metalloproteasesAmino Acids, 2010
- Matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs): Positive and negative regulators in tumor cell adhesionSeminars in Cancer Biology, 2010
- Matrix Metalloproteinases: Regulators of the Tumor MicroenvironmentCell, 2010
- Anti-angiogenic therapy in renal cell cancerBJU International, 2007
- Anti-angiogenic therapy in the treatment of advanced renal cell cancerCancer Treatment Reviews, 2007
- Matrix metalloproteinase-9 polymorphisms and renal cell carcinoma in a Japanese populationCancer Letters, 2006
- Increased Expression of Matrix Metalloproteinase 9 Correlates with Poor Prognostic Variables in Renal Cell CarcinomaEuropean Urology, 2003
- Matrix Metalloproteinase Activity in Urine of Patients with Renal Cell Carcinoma Leads to Degradation of Extracellular Matrix proteins: possible use as a Screening AssayJournal of Urology, 2003
- Angiogenesis in renal cell carcinoma: Evaluation of microvessel density, vascular endothelial growth factor and matrix metalloproteinasesInternational Journal of Urology, 2002